Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer
Titel:
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer
Auteur:
Mok, T.S. Geater, S.L. Iannotti, N. Thongprasert, S. Spira, A. Smith, D. Lee, V. Lim, W.T. Reyderman, L. Wang, B. Gopalakrishna, P. Garzon, F. Xu, L. Reynolds, C.